Displaying results 1 - 1 of 1
Clear search
Isogenica licenses CIS Display Technology to Aro Biotherapeutics
Isogenica Ltd today announced that it has signed a new licensing agreement with Aro Biotherapeutics Company (Aro) of Philadelphia. USA, that will leverage each other’s strengths in recombinant protein technologies and biopharmaceutical development.